Salus Therapeutics' Acquisition

Salus Therapeutics was acquired by Genta on August 19, 2003.

Salus Therapeutics develops oligonucleotide pharmaceuticals intended to block or regulate the production of disease-related proteins at the genetic level.…

Articles about Salus Therapeutics' Acquisition: